N@N

Bohai Pharmaceuticals Announces Availability of New Investor Fact Sheet

^{Published on 2010-08-18 05:05:51 - Market Wire}
 

YANTAI, China--([ BUSINESS WIRE ])--Bohai Pharmaceuticals Group, Inc. (OTCBB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine in China, today announces the availability of a new online Investor Fact Sheet.

"Bohai is able to take advantage of the increasing demand for Traditional Chinese Medicine through our focused corporate growth strategy, which emphasizes quality ingredients and proactive sales and marketing efforts as we leverage the protected manufacturing status and national insurance coverage for certain of our pharmaceutical products."

aAs part of our goal in keeping investors informed with the latest developments at Bohai, we are releasing our new fact sheet, which we plan to update regularly,a said Mr. Hongwei Qu, President and Chief Executive Officer of Bohai Pharmaceuticals Group. aBohai is able to take advantage of the increasing demand for Traditional Chinese Medicine through our focused corporate growth strategy, which emphasizes quality ingredients and proactive sales and marketing efforts as we leverage the protected manufacturing status and national insurance coverage for certain of our pharmaceutical products.a

Mr. Qu continued, aWe believe Bohai Pharmaceuticals is a strategically well positioned TCM manufacturer with long term growth potential, and we look forward to providing our investors with updates on our progress over the coming weeks and months.a

The Investor Fact Sheet provides a concise overview of Bohai Pharmaceuticalsa™ business model and the companya™s various opportunities in Chinaa™s healthcare market, and will prove an important resource for existing shareholders and prospective investors alike.

The Fact Sheet is available at:
[ www.trilogy-capital.com/autoir/boph_autoir.html ]

About Bohai Pharmaceuticals Group, Inc.

Based in the city of Yantai, Shandong Province, China, Bohai Pharmaceuticals Group, Inc. (OTCBB: BOPH) is engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on Traditional Chinese Medicine in China. Bohaia™s medicines address common health problems such as rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. Bohaia™s products are sold either by prescription through hospitals or over-the-counter through local pharmacies and retail drug store chains. Bohai has approximately 600 employees, including approximately 300 sales representatives, operating from 20 offices throughout China. Bohaia™s lead products, Tongbi Capsules and Tablets and Lung Nourishing Cream, are eligible for reimbursement under Chinaa™s National Medical Insurance Program. In fiscal year ended June 30, 2009, these products accounted for more than 50% of Bohaia™s revenues.

Cautionary Note Regarding Forward Looking Statements

This press release, the Investor Fact Sheet referred to herein and the statements of representatives of Bohai Pharmaceuticals Group, Inc. (the aCompanya) related thereto contain, or may contain, among other things, aforward-looking statementsa within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are aforward-looking statements,a including any other statements of non-historical information. These forward-looking statements are subject to significant known and unknown risks and uncertainties and are often identified by the use of forward-looking terminology such as aprojects,a amay,a acould,a awould,a ashould,a abelieves,a aexpects,a aanticipates,a aestimates,a aintends,a aplans,a or similar expressions. All forward-looking statements involve material assumptions, risks and uncertainties, and the expectations contained in such statements may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Companya™s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the factors and risks discussed in the periodic reports that the Company files with the Securities and Exchange Commission ([ http://www.sec.gov ]). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. The Company undertakes no duty to update these forward-looking statements except as required by law.